Market closed
QuidelOrtho Corporation/$QDEL
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About QuidelOrtho Corporation
QuidelOrtho Corp is engaged in the development, manufacturing, and marketing of rapid diagnostic testing solutions. The company is engaged in immunoassay and molecular testing, clinical chemistry and transfusion medicine which helps clinicians and patients to make decisions across the globe. Geographically the company has its presence in North America, EMEA, China and Other countries. It generates majority if the revenue from North America.
Ticker
$QDEL
Sector
Trading on
Industry
Health Care Equipment & Supplies
Headquarters
Employees
7,100
Website
QDEL Metrics
BasicAdvanced
$2.9B
Market cap
-
P/E ratio
-$27.85
EPS
0.10
Beta
-
Dividend rate
Price and volume
Market cap
$2.9B
Beta
0.1
52-week high
$75.86
52-week low
$29.74
Average daily volume
1.2M
Financial strength
Current ratio
1.375
Quick ratio
0.669
Long term debt to equity
73.763
Total debt to equity
85.493
Interest coverage (TTM)
0.66%
Management effectiveness
Return on assets (TTM)
1.04%
Return on equity (TTM)
-45.79%
Valuation
Price to revenue (TTM)
1.024
Price to book
0.91
Price to tangible book (TTM)
-7.62
Price to free cash flow (TTM)
-26.315
Growth
Revenue change (TTM)
-9.74%
Earnings per share change (TTM)
-14,185.94%
3-year revenue growth (CAGR)
14.63%
3-year earnings per share growth (CAGR)
10.49%
What the Analysts think about QDEL
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for QuidelOrtho Corporation stock.
QDEL Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
QDEL Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
QDEL News
AllArticlesVideos
Carlyle Sells QuidelOrtho Shares, Analyst Sees Overhang Lifted
Benzinga·1 month ago
Powell Industries Reports Weak Sales, Joins Target, QuidelOrtho And Other Big Stocks Moving Lower In Wednesday's Pre-Market Session
Benzinga·1 month ago
QuidelOrtho Corporation Announces Pricing of Secondary Offering of Common Stock by the Carlyle Group
Business Wire·1 month ago
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for QuidelOrtho Corporation stock?
QuidelOrtho Corporation (QDEL) has a market cap of $2.9B as of December 21, 2024.
What is the P/E ratio for QuidelOrtho Corporation stock?
The price to earnings (P/E) ratio for QuidelOrtho Corporation (QDEL) stock is 0 as of December 21, 2024.
Does QuidelOrtho Corporation stock pay dividends?
No, QuidelOrtho Corporation (QDEL) stock does not pay dividends to its shareholders as of December 21, 2024.
When is the next QuidelOrtho Corporation dividend payment date?
QuidelOrtho Corporation (QDEL) stock does not pay dividends to its shareholders.
What is the beta indicator for QuidelOrtho Corporation?
QuidelOrtho Corporation (QDEL) has a beta rating of 0.1. This means that it is less volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 0.5 would mean it moves half as much as the market.